Quadruple Marker Test: Screening and Benefits

Prenatal screening is a foundational aspect of obstetric care, providing expectant parents with vital information regarding fetal health. For pathologists and clinicians, the quadruple marker test represents a specific window into fetal development during the second trimester.

While newer technologies like Non-Invasive Prenatal Testing (NIPT) have gained traction, the quad screen maintains its relevance due to its balance of cost-effectiveness and broad screening capabilities.

Defining the Quadruple Marker Test Parameters

The quadruple marker test is a maternal blood test that measures four specific substances produced by the fetus and the placenta. It is frequently termed the quad screen.

Unlike the first-trimester double marker test, which focuses on PAPP-A and free Beta-hCG, this panel expands the biochemical profile to improve detection rates for neural tube defects and chromosomal abnormalities.

The Quadruple Marker Test Parameters

Alpha-fetoprotein (AFP) A protein produced by the fetal liver.

Unconjugated Estriol (uE3): An estrogen produced by both the placenta and the fetal liver.

Human Chorionic Gonadotropin (hCG): A hormone produced by the placenta.

Inhibin-A: A protein secreted by the placenta and ovaries.

By analysing these four markers in conjunction with maternal age, weight, ethnicity, and gestational age, you can calculate a risk probability.

Timing and Gestational Windows

Precision is everything when scheduling these screenings. The quadruple marker test weeks of eligibility generally span from the 15th to the 22nd week of pregnancy.

However, the optimal quadruple marker test time falls between the 16th and 18th weeks. Results derived outside the window may lose significant predictive power, leading to unnecessary anxiety or a false sense of security for the patient.

Quadruple Marker Test vs Anomaly Scan

A common point of discussion involves the quadruple marker test vs anomaly scan. While both are performed in the second trimester, they serve distinct purposes. The quadruple marker test in pregnancy is a biochemical screen aimed at assessing the statistical risk of Trisomy 21 (Down Syndrome), Trisomy 18 (Edwards Syndrome), and Open Neural Tube Defects (ONTDs).

In contrast, the anomaly scan (level II ultrasound) is a structural survey. It visualises the physical anatomy of the fetus to detect morphological deviations. Using an anomaly scan and quadruple marker test together provides a holistic view, as some structural issues might not correlate with biochemical markers and vice versa.

Interpreting the Results: The Normal Range and Beyond

When you review a quadruple marker test report, you are looking at Multiples of the Median (MoM). A quadruple marker test normal report indicates that the risk levels fall below the established laboratory cut-off (usually 1:250 or 1:270 for Down Syndrome).

Condition	AFP Levels	uE3 Levels	hCG Levels	Inhibin-A Levels
Down Syndrome (Trisomy 21)	Low	Low	High	High
Edwards Syndrome (Trisomy 18)	Low	Low	Low	N/A
Neural Tube Defects	High	Normal

The quadruple marker test normal range is highly dependent on accurate gestational dating. If the dating is off by even a few days, the quadruple marker test result range can shift into "screen positive" territory incorrectly.

Why Laboratory Efficiency Matters

Processing these tests requires meticulous data handling. Given that the quadruple marker test uses complex algorithms to calculate risk, any manual entry error regarding maternal weight or gestational age can skew the entire quadruple marker test results.

This is where Flabs Pathology Software transforms your workflow. With Automated Data Capture, you eliminate the risks associated with manual transcription. Our software integrates seamlessly with immunoassay analysers like the Abbott Architect Series, Siemens IMMULITE, or Roche Elecsys.

By leveraging Real-Time Data Processing, your lab can provide a faster quadruple marker test accuracy profile, ensuring that clinicians receive reports exactly when they need them.

Double Marker vs Quadruple Test

​Practitioners often weigh the difference between the double marker and the quadruple test when advising patients who missed early screening.

The double marker is performed in the first trimester (weeks 11-14) and, when paired with a Nuchal Translucency (NT) scan, gives high sensitivity for chromosomal issues.

The quadruple marker test acts as the primary screening tool for those who:

• Began prenatal care later in the second trimester.
• Reside in areas where NT ultrasound expertise is limited.
• Require screening for neural tube defects, which the double marker does not cover.

Is the Quadruple Marker Test Necessary?

Patients frequently ask: is quadruple marker test necessary? From a clinical perspective, it is a non-invasive way to identify pregnancies that might require more invasive diagnostic procedures like amniocentesis.

While it is not a definitive test, it serves as an essential filter. High-risk quadruple marker test report findings prompt further investigation. It allows for better birth preparation or medical intervention.

Improving Lab Accuracy with Flabs LIS

Precision in reporting is the backbone of pathology. When you manage high volumes of prenatal screens, the Flabs Pathology Software provides:

Effortless Integration: Connect your existing analysers with minimal technical hurdles.

Error Mitigation: Automated algorithms verify that the data matches the patient profile before the report is finalised.

Custom Alerts: Get notified immediately if an analyser flags a result that deviates from the expected quadruple marker test normal range.

Comprehensive Reporting: Deliver clear, easy-to-read reports that help doctors explain quadruple marker test results to expectant parents.

​Final Clinical Thoughts
The quadruple marker test is a staple in second-trimester care. Its ability to screen for both chromosomal issues and structural defects like spina bifida makes it a versatile tool for the modern obstetrician.

As a pathologist, your role in ensuring the accuracy of these markers is paramount. Utilising advanced LIS solutions ensures that the data leaving your lab is reliable, timely, and secure.

Streamline Your Lab Operations Today

Flabs Machine Interfacing ensures your chemistry and immunoassay analysers communicate directly with your LIMS. Reduce turnaround times and improve data integrity for sensitive prenatal screenings.

Start Your 5-Day Free Trial Now!